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Among the distinguishing characteristics of members of the gamma-2 herpesvirus family is the expression of a mammalian D-type cyclin homolog,
termed v-cyclin. Murine gammaherpesvirus 68 (γHV68) is a γ2-herpesvirus that can infect inbred and outbred strains of mice, providing a genetic
system for the study of gammaherpesvirus pathogenesis. Disruption of the v-cyclin gene of γHV68 results in a virus that establishes latency in infected
mice to wild-type levels, but is severely attenuated for virus reactivation [van Dyk, L.F., Virgin IV, H.W., Speck, S.H., 2000. J. Virol. 74:7451–7461].
Transcriptional regulation of the γHV68 v-cyclin has not been defined. We report here the initial characterization of the v-cyclin transcript expressed in
permissive murine fibroblasts. Based on 5′ mapping of the v-cyclin transcript, we identified a promoter that is involved in driving v-cyclin expression
during virus replication. In addition, we determined that the promoter is responsive to the major viral lytic transactivator, Rta, encoded by orf 50. Using
reporter plasmids we have analyzed both basal and Rta-induced v-cyclin promoter activity, initially identifying two regions of the v-cyclin promoter
important for both basal and Rta-induced activity. Notably, only one of these regions could be shown to confer Rta responsiveness on a reporter construct
containing the hsp70 TATA box. The importance of this region in regulating v-cyclin expression during virus replication was confirmed by introducing
these mutations into the context of the viral genome and assessing v-cyclin expression following infection of permissive murine fibroblasts in tissue
culture. In addition, we show that mutations that severely cripple Rta-induction of v-cyclin expression did not adversely impact virus reactivation from
splenocytes recovered from latently infected mice, indicating that alternatively regulated v-cyclin gene expression is required for virus reactivation.
© 2007 Elsevier Inc. All rights reserved.Keywords: γ-herpesvirus; Cyclin; Transcrption; Virus replicationIntroduction
Infection of laboratory mice with murine gammaherpesvirus
68 (γHV68), a member of the gammaherpesvirus family related
to the human gammaherpesviruses Epstein Barr virus (EBV) and
Kaposi's sarcoma-associated herpesvirus (KSHV or HHV-8),
leads to an initial lytic infection in tissues including the lungs and
spleen of the animal. Following resolution of the lytic infection,
a lifelong latent infection that is marked by periodic virus
reactivation predominates in the host (Speck and Virgin, 1999).
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doi:10.1016/j.virol.2007.03.021vation from latent infection requires efficient transduction of
reactivation stimuli and subsequent modulation of the viral and
host factors that allow for productive virus infection in reac-
tivating cells (Roizman, 2001). A full understanding of γHV68
reactivation therefore requires identification of not only the viral
proteins that are required for reactivation, but also the host and
viral proteins that modulate transcription of these viral genes.
Genetic studies of γHV68 have led to the identification of a
number of proteins, including M2 and v-cyclin, that play
important roles in virus reactivation (Husain et al., 1999; Jacoby
et al., 2002; van Dyk et al., 2000, 2003; Virgin et al., 1999). M2
function is important not only for virus reactivation, but also for
the establishment of latency in the spleen (Herskowitz et al.,
2005; Jacoby et al., 2002). In contrast, v-cyclin null viruses
establish latency to wild-type levels in infected mice, but
display a profound defect in virus reactivation from latently
Fig. 1. Mapping the v-cyclin transcript in γHV68 infected NIH 3T12 fibroblasts.
(A) The locations of the predicted ORFs for v-cyclin and v-Bcl-2(M11) are
depicted in their genomic orientation. Filled black arrows are labeled with the
genomic coordinates position of the terminal nucleotide of 5′RACE products
generated using RNA from infected NIH 3T12 fibroblasts. The position of the
v-cyclin-specific PCR primer 72RACE5′ is also indicated. The filled gray arrow
is labeled with the genomic coordinate of the terminal nucleotide position of
3′RACE products generated from the same RNA template. Based on proximity
to the 3′ terminus, the proposed polyA signal utilized in generation of the v-
cyclin lytic transcript is indicated. The position of the PCR primer used in the 3′
RACE reactions, 72RACE3′ is also labeled. (B) Primer extension mapping of
the 5′end of the v-cyclin transcript in NIH 3T12 fibroblasts infected for 12, 24,
36, and 48 h of uninfected cells. The open circle marks the position of the 3
major extension products detected under these conditions. The deduced position
(open circle) and the range of genomic coordinates of the 5′termini of the v-
cyclin transcripts are indicated on the genomic depiction in panel A. The
position of the primer used in the analysis, 72RACE5′ is also indicated.
251R.D. Allen III et al. / Virology 365 (2007) 250–259infected cells upon explant into tissue culture (Hoge et al., 2000;
van Dyk et al., 2000). The in vivo relevance of this phenotype is
confirmed by the analysis of γHV68 infection in B cell-
deficient mice, where loss of v-cyclin function leads to a
progressive loss of latently infected cells and clearance of
chronic infection (van Dyk et al., 2003). Because the function of
v-cyclin is restricted to reactivation from latency in our system,
it is possible to investigate the specific role of v-cyclin cis and
trans transcriptional regulatory factors in virus reactivation.
In the following study, we report the characterization of the
structure of a v-cyclin transcript found in lytically infected
murine NIH 3T12 fibroblasts. In addition, we have identified
and characterized the v-cyclin lytic cycle-associated promoter.
Using recombinant γHV68 v-cyclin promoter mutants, we have
investigated the role of this promoter in regulating v-cyclin
expression during virus replication in permissive murine
fibroblasts. Finally, we have assessed the impact of mutations
that impair lytic cycle-associated v-cyclin expression on virus
reactivation from latently infected cells recovered from γHV68
infected mice.
Results
Characterization of the v-cyclin transcript in lytically infected
murine fibroblasts
During our initial analysis of v-cyclin function, we
determined that v-cyclin protein expression was readily
detectable in lytically infected NIH 3T12 fibroblasts by 24 h
post-infection (van Dyk et al., 1999). In addition, transcriptional
profiling studies of γHV68 have demonstrated that v-cyclin
mRNA is transcribed in the presence of cycloheximide during
lytic infection, a characteristic of herpesvirus immediate-early
transcripts (Martinez-Guzman et al., 2003). To identify the
transcriptional control regions for v-cyclin, we first used RACE
and primer extension analyses to identify the termini of the v-
cyclin transcript. 5′ RACE was performed on RNA prepared
from murine NIH 3T12 fibroblasts (NIH 3T12s) infected with
wt virus for 24 h. Using the primer 72RACE5′ (Fig. 1A), RACE
products were generated and subcloned. Based on sequencing
multiple independent clones, a 5′ end for the v-cyclin transcript
was defined between nucleotide positions 103,238 and 103,255
(Fig. 1A). Primer extension analysis using the 72RACE5′
primer and polyA RNA from productively infected NIH 3T12
fibroblasts, harvested at 12, 24, 36, and 48 h post-infection,
yielded three major bands that mapped to a region extending
between nucleotide positions 103,248 and 103,258 in the viral
genome (Fig. 1B).
The 3′ end of the v-cyclin message was also mapped by 3′
RACE using RNA prepared from NIH 3T12 fibroblasts in
conjunction with the primer 72RACE3′ (Fig. 1A). Based on the
DNA sequence of the subcloned 3′ RACE products, the
polyadenylation signal used in transcription of the v-cyclin
message is located within the final two codons of the v-cyclin
orf (between nucleotide positions 102,430 and 102,435) and the
3′ end of the message extends to nucleotide position 102,412
(Fig. 1A). Thus, during lytic infection, the γHV68 v-cyclin isencoded by an unspliced transcript, typical of lytic herpesvirus
transcripts. This is in contrast to the spliced v-cyclin transcripts
identified during latent infection of the closely related
gammaherpesviruses, herpesvirus saimiri (HVS) and KSHV
(Dittmer et al., 1998; Hall et al., 2000; Kedes et al., 1997; Sarid
et al., 1999).
Identification of a v-cyclin promoter active in murine
fibroblasts
Following the characterization of v-cyclin gene transcription
during lytic infection, we sought to identify the v-cyclin lytic
cycle-associated v-cyclin promoter. Regions of the viral genome,
including the mapped 5′ end of the v-cyclin transcript, were
subcloned into a luciferase reporter vector. A construct containing
sequences spanning the region between nucleotide 103,183 and
103,982 (72/800) was transiently transfected into NIH 3T12
fibroblasts, and subsequent luciferase assays on protein extracts
from these cells indicated promoter activity in this region (Fig.
Fig. 2. (A) Identification of a v-cyclin promoter active in NIH 3T12 fibroblasts.
Reporter constructs (1 μg) containing defined regions of the γHV68 genome
upstream of the v-cyclin ATG start codon (see Materials and methods) were
transiently transfected into NIH 3T12 fibroblasts. Forty-eight hours later,
transfected cell extracts were prepared and assayed for luciferase activity. The
relative light units (RLUs) detected from transfectants containing candidate
promoter regions are compared to those detected cells transfected with the empty
luciferase control vector, pGL3. Data presented here are representative of three
independent experiments. (B) Sequence of the minimal v-cyclin promoter in
NIH 3T12 fibroblasts. The minimal promoter extends from +57 to −243 relative
to the most proximal mapped site of transcription initiation. 5′ terminal
nucleotide positions based on RACE (filled arrows) or primer extension analysis
(open arrows) are indicated, as is the putative TATA box (boxed sequence). The
position of a selection of transcription factor consensus binding sites (overlines)
was determined based on transcription factor binding site analysis using the
TESS interface of the TRANSFAC database.
Fig. 3. Linker scanning mutagenesis of the v-cyclin promoter region. (A)
Discrete regions of the v-cyclin minimal promoter, L1-LS9 (overlines), were
individually mutated from the wild-type sequence presented in the figure to that
of the AscI linker, 5′AGGCGCGCCA3′. 5′ terminal nucleotide positions based
on RACE (filled arrows) or primer extension analysis (open arrows) are
indicated, as is the putative TATA box (boxed sequence). (B) Characterization of
72/800LS mutant constructs in NIH 3T12 fibroblasts. The control pGL3-basic
vector, 72/800, or the Linker Scanning mutants LS1–LS12 (1ug each) were
cotransfected into 3T12 fibroblasts along with 1 μg of a control expression
vector, pBK. Whole cell lysates from transfected cells were prepared 48 h after
transfection and analyzed for luciferase activity. Results are presented as RLUs.
Data presented here are representative of three independent experiments.
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transfected with constructs containing the region between
nucleotide 103,183 and 103,482 (72/300, Fig. 2A). Deletion of
an additional 100 bp from the 5′ end of the promoter (73/200)
resulted in an approximately 5-fold drop in promoter activity
(Fig. 2A). Only background levels of luciferase activity could be
detected in cells transfected with a construct containing sequences
extending from nucleotide 103,182 to 103,382 (73/100 Fig. 2A).
In this manner, the minimal v-cyclin promoter active in NIH
3T12 fibroblasts was mapped to a region between nucleotides
103,182 and 103,482 (+57 to −243 relative to the most proximal
mapped site of transcription initiation).
Within the minimal promoter, a candidate TATA box lies
between bp 103,280 and 103,285 (Fig. 2B). In addition, analysis of
the minimal v-cyclin promoter sequence for transcription factor
binding sites using the TRANSFAC database (URL: http://www.
cbil.upenn.edu/tess) revealed strong consensus binding sites for a
number of cellular transcription factors (Fig. 2B). Among the
consensus sites identified was that for MEF-2 binding. Previouswork from our lab, as well as others, has demonstrated a role for
human MEF2D binding in the maintenance of a latent EBV
infection through MEF-2D mediated recruitment of histone
deacetylases to the immediate-early BZLF1 gene promoter
(Gruffat et al., 2002; Liu et al., 1997). Assigning a role for this
and other transcription factors in v-cyclin lytic cycle-associated
promoter function required that we first determine those regions of
the promoter that are important for maintaining basal promoter
function during lytic infection.
Linker scanning mutagenesis of the lytic cycle-associated
v-cyclin promoter and identification of an Rta responsive
cis-element
To begin mapping the regulatory regions within the v-cyclin
lytic cycle-associated promoter, a consecutive series of nine
10 bp linker scanning (LS) mutations were introduced into the
region extending upstream from the v-cyclin 5′end, as described
in Materials and methods (Fig. 3A). Luciferase constructs
carrying these LS mutations (LS1–LS9) in the context of the 72/
800 promoter construct were tested for basal promoter activity,
Fig. 4. The v-cyclin lytic cycle-associated promoter is Rta-responsive. (A) The
minimal Rta-responsive v-cyclin promoter was mapped by cotransfecting 1 μg
luciferase reporter constructs containing defined γHV68 genomic regions (see
Materials and methods) with either 1 μg of the empty expression plasmid pBK,
or 1 μg of the Rta expression construct pBKRta in NIH 3T12 cells. Luciferase
activity for each reporter construct following cotransfection with pBKRta was
compared to that following cotransfection with pBK. The quotient of these two
values is presented as fold induction by Rta for each construct. (B) Linker
scanning mutants LS1–LS9 were assessed for their capacity to be induced by
Rta. Luciferase activity for each LS construct following cotransfection with pBK
in NIH 3T12 cells (Fig. 3B) and fold induction was calculated. (C) Putative Rta
response elements within the v-cyclin promoter were assessed independently of
the full v-cyclin promoter with use of the heterologous cellular hsp70 basal
promoter reporter vector, hsp-tata pGL3. Two micrograms of the indicated
reporter vectors was cotransfected with 2 μg of either pBK or pBKRta in 293T
cells. The quotient of these two values is presented as fold induction by Rta for
each construct. Data presented here are representative of three independent
experiments.
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fibroblasts (Fig. 3B). As can be seen in Fig. 3B, the LS4 and
LS7 mutations resulted in the greatest loss of v-cyclin promoter
activity, with LS4 down by a factor of five as compared to wild-
type, and LS7 activity reduced nearly ten-fold.
Given that the levels of v-cyclin transcript are lower in the
presence of cycloheximide, we sought to determine whether the
major viral lytic transactivator, Rta, plays a role in regulating
v-cyclin lytic cycle-associated promoter function (Martinez-
Guzman et al., 2003). NIH 3T12 fibroblasts were co-transfected
with v-cyclin promoter-driven reporter constructs and either an
empty expression plasmid (PBK), or an expression plasmid into
which the γHV68 Rta cDNA had been cloned (PBKRta). Co-
transfection of the Rta expression plasmid with the 72/800
promoter construct led to a significant increase in luciferase
activity, as compared to cells cotransfected with the 72/800 and
the empty control expression vector PBK (Fig. 4A). Rta
induction of reporter gene expression from the 72/200 construct
was comparable to that from the 72/800 construct (Fig. 4A).
However, a construct that lacked basal promoter activity, 72/
100, was not induced by Rta (Fig. 4A). Based on this result, we
conclude that the v-cyclin promoter active during virus
replication in murine fibroblasts is Rta responsive, and that
Rta inducibility maps to a region between bp 103,183 and
103,383 in the viral genome.
To more precisely map regions of the promoter required for
Rta induction, the WT and linker scanning v-cyclin promoter
mutants were cotransfected with either the control PBK or
PBKRta expression vectors into NIH 3T12 fibroblasts. The
relative luciferase activity under each condition was compared,
and the fold induction by Rta was plotted for each construct (Fig.
4B). Mutant constructs LS1, LS2, LS3, LS6, and LS8 all were
induced by Rta to within 2-fold of wild-type v-cyclin promoter
levels (Fig. 4B). However, inducibility by Rta was reduced by a
factor of 10 in promoter mutant LS7 (Fig. 4B). Less significant
reductions in Rta inducibility were observed with mutants LS4,
LS5, and LS9, suggesting that Rta may act to transactivate the v-
cyclin promoter through more than one site within the v-cyclin
gene promoter (Fig. 4B). Alternatively, the reduction of Rta
transactivation for some of the linker scanning mutants could
reflect disruption of a cis-element(s) critical for basal and induced
promoter activity. Indeed, both the LS4 and LS5 mutants are
predicted to disrupt the putative TATA box (see Fig. 3A).
Notably, inspection of the DNA sequence of the v-cyclin
lytic promoter region did not reveal any consensus Rta binding
sites, suggesting that Rta may be modulating promoter activity
through an indirect mechanism. Consistent with the hypothesis,
the LS mutants that were most impaired for Rta inducibility
were the same mutants that displayed impaired basal promoter
function (compare Figs. 3B and 4B). If Rta is acting indirectly
to modulate v-cyclin promoter function – thereby leading to a
general upregulation of basal v-cyclin promoter activity – then
it follows that those LS mutations that most affected basal
promoter activity would have the greatest impact on Rta
inducibility.
To distinguish between a role for the implicated promoter
regions in mediating Rta activation of the v-cyclin gene
Fig. 5. v-cyclin lytic promoter function is necessary for expression of v-cyclin in
lytically infected NIH 3T12 fibroblasts. Cells were infected with γHV68/LS4
(LS4, lane 1), γHV68/LS5 (LS5, lane 2), γHV68/LS6 (LS6, lane 3), γHV68/
LS7 (LS7, lane 4), γHV68/LS8 (LS8, lane 5), γHV68/LS9 (LS9, lane 6),
γHV68 (WT, lane 7), γHV68 72.Stop (v-cyclin stop mutant, lane 8), or mock
infected (lane 9) at an MOI of 5. Eighteen hours post-infection, cell lysates were
prepared, quantitated, and 30 μg of total protein was loaded onto a 15%
polyacrylamide gel. Following incubation with anti-v-cyclin antibody, immu-
noblots were stripped and re-probed first with the anti-ORF 59 antibody to
control for effects of the mutations on other viral proteins and then with the anti-
β-actin antibody to control for protein loading.
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for promoter activity, we cloned these regions upstream of a
minimal heterologous promoter-driven reporter construct. This
construct contains the TATA box and surrounding basal
promoter sequences of the cellular hsp70 gene cloned upstream
of the firefly luciferase reporter gene (Lukac et al., 2001). As
shown in Fig. 4C, the wt promoter sequences corresponding to
the sequences mutated in the LS4–6 mutants did not confer Rta
inducibility on the minimal hsp promoter-driven reporter
construct. However, activity of the heterologous reporter
construct containing the wt promoter sequences corresponding
to the sequences mutated in the LS6–9 mutants was strongly
upregulated by Rta expression. This confirms the presence of an
Rta responsive cis-element within the v-cyclin promoter
mapping within the regions from bp 103,307–103,346 in the
viral genome. It is possible that the failure to detect Rta
activation of the heterologous reporter construct containing the
LS4–6 region was due to failure to include sequences upstream
of the LS4 region. However, as shown below, subsequent
analysis of recombinant viruses harboring these linker scanning
mutations largely rules out this possibility.
Impact of mutating candidate Rta-responsive regions in the
v-cyclin promoter on v-cyclin expression during lytic infection
of NIH 3T12 fibroblasts
As with any promoter-driven reporter construct, transient
transfection analyses can be misleading because it is difficult to
assess the influence that contextual factors (e.g., promoter length,
neighboring gene effects, and chromatin structure) may have on
mutant phenotypes. In an effort to overcome this limitation, and to
enable testing of the promoter mutants in a biologically relevant
context, the linker scanning mutations were introduced directly
into the γHV68 genome. The LS4–LS9 mutations were each
engineered into the viral genome by allelic exchange mutagenesis
of the γHV68-BAC (described in Materials and methods) (Adler
et al., 2001; Smith and Enquist, 1999). To excise the BAC
sequence from the mutant viruses, viral stocks were generated in
Vero cells that stably express Cre-recombinase. The floxed γHV68
and γHV68/72LS mutant virus stocks were then used to infect
NIH 3T12 fibroblasts at an MOI of 5. Infections were allowed to
proceed for 18 h, at which time whole cell protein lysates were
prepared from infected cells. Protein lysates were analyzed by
immunoblot for the expression of v-cyclin, using a previously
described rabbit polyclonal antisera generated against the v-cyclin
(van Dyk et al., 1999), as well as a chicken antibody raised against
two peptides from orf 59 encoded early antigen (Fig. 5). Infection
with γHV68/72LS4, γHV68/72LS5, and γHV68/72LS6 mutant
viruses each yielded wild-type levels of v-cyclin expression as
measured at 18 h post-infection (Fig. 5, lanes 1–3). Thus, the
changes observed in vitro in either basal promoter function or Rta
induction of reporter constructs carrying these mutations did not
result in a significant changes in v-cyclin expression during lytic
infection. The latter result is also consistent with the failure to
observe Rta-inducible activity of the heterologous promoter
construct containing the wt sequences corresponding to the LS4–
6 mutants. In contrast, v-cyclin expression in cells infected withγHV68/72LS7, γHV68/72LS8, and γHV68/72LS9 mutant
viruses was significantly reduced compared to v-cyclin expression
following wt virus infection (Fig. 5, lanes 4–6). Notably,
expression of the early antigen encoded by orf 59 was unaffected
by the alteration in v-cyclin expression—consistent with the
absence of any detectable growth defect of v-cyclin mutant
viruses under these culture conditions. Thus, the regions disrupted
by LS7, LS8, and LS9 are important for the regulation of v-cyclin
expression during lytic viral infection of NIH 3T12 fibroblasts,
while the regions disrupted by LS4, LS5, and LS6 do not appear
to play a critical regulatory role at this stage of virus infection.
Role of the v-cyclin lytic cycle-associated promoter in virus
reactivation from latency
Previous reports have demonstrated that v-cyclin expression
is dispensable during lytic replication both in vitro and in vivo
(van Dyk et al., 2000). More recently we have shown that
following low dose intranasal inoculation that there is a role for
the v-cyclin in acute virus replication in vivo (Upton and Speck,
2006). In addition, we have shown that the v-cyclin does play a
critical role in the reactivation of virus from latent infection in
vivo (van Dyk et al., 2000; Upton and Speck, 2006). Thus far,
we have established that disruption of the v-cyclin lytic cycle-
associated promoter can result in diminished v-cyclin expres-
sion during virus replication in vitro. To extend these results, we
investigated the role of the v-cyclin lytic cycle-associated
promoter in directing v-cyclin expression during reactivation
from latency. If the lytic cycle-associated promoter plays a
critical role in driving transcription of the v-cyclin gene during
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of this promoter would result in a decrease in γHV68
reactivation similar to that seen with the v-cyclin null virus
(72Stop) (van Dyk et al., 2000; Upton and Speck, 2006). In
addition, because there are fewer viral genomes in latently
infected cells than in lytically infected cells, one might expect
that defects in v-cyclin expression would have a more profound
effect on reactivation than on lytic replication.
To determine whether those promoter mutations that
decrease v-cyclin expression during lytic infection might also
disrupt virus reactivation, C57BL/6 mice were infected
intranasally with 1000 pfu of WT, 72Stop, γHV68/72LS7,
γHV68/72LS8, or γHV68/72LS9 viruses. Sixteen days post-
infection, spleens were harvested and analyzed for the
frequency of splenocytes that reactivated virus ex vivo (Fig.
6). Splenocytes infected with the 72Stop virus (Fig. 6, filled
triangles) reactivated virus at an approximately 10-fold lower
frequency than WT infected splenocytes (Fig. 6, filled squares).
However, splenocytes infected with γHV68/72LS7, γHV68/
72LS8, or γHV68/72LS9 viruses all reactivated to wild-type
levels (Fig. 6, open symbols). Notably, the v-cyclin linker
scanning mutant viruses also behaved as wild-type following
intraperitoneal infection and measurement of reactivation from
infected peritoneal exudate cells 42 days post-infection (data
not shown). These results indicate that mutations in those
regions of the v-cyclin lytic cycle-associated promoter that are
most important for regulating v-cyclin expression during lytic
infection, do not lead to a loss of reactivation efficiency in vivo.
It is possible that the control of virus reactivation from latency
maps to other regions of the v-cyclin lytic cycle-associated
promoter. However, none of the other v-cyclin LS mutants we
have tested (γHV68/72LS4, γHV68/72LS5, and γHV68/
72LS6) exhibits diminished reactivation from latency comparedFig. 6. The v-cyclin lytic promoter regions mutated in γHV68/72LS7, γHV68/
72LS8, and γHV68/72LS9 viruses are dispensable for virus reactivation. Mice
were infected intranasally with 1000 pfu of virus in 20 μl of DMEM.
Splenocytes were harvested 16 days after infection and plates on MEF
monolayers to assay for virus reactivation (see Materials and methods). Results
from infections with the following viruses are shown: WT (filled squares),
72Stop (filled triangles), γHV68/72LS7 (LS7, open diamonds), γHV68/72LS8
(LS8, open circles), and γHV68/72LS9 (LS9, open squares). The data were
compiled from at least two independent experiments, each containing four or
five mice per group, and standard error of the mean is indicated.to WT virus (data not shown). This could reflect the fact that
none of the linker scanning mutants completely abrogates v-
cyclin expression, at least as determined in lytically infected
murine fibroblasts (see Fig. 5). Alternatively, the failure of the
LS promoter mutations to recapitulate the 72Stop reactivation
phenotype may point to the existence of a separate v-cyclin
promoter which is responsible for the regulation of v-cyclin
expression during virus reactivation.
Discussion
Using RT-PCR or microarray techniques, the v-cyclin
transcript has been detected during both lytic and latent virus
infection in γHV68 and the related gammaherpesviruses,
KSHV and HVS (Dittmer, 2003; Ebrahimi et al., 2003; Jenner
et al., 2001; Martinez-Guzman et al., 2003). Published work on
v-cyclin transcript structure and gene regulation has focused on
those transcripts that are produced in latently infected cells
(Dittmer et al., 1998; Hall et al., 2000; Kedes et al., 1997; Sarid
et al., 1999). During KSHV latency, the v-cyclin gene is
transcribed as an alternatively spliced message that is 3′
coterminal with messages encoding the KSHV LANA and v-
FLIP, all driven by a common promoter (Dittmer et al., 1998;
Kedes et al., 1997; Sarid et al., 1999). The transcriptional
analysis of the v-cyclin gene reported here has focused on
identifying transcripts from lytically infected cells. We have
characterized a v-cyclin transcript present during lytic infection
of murine NIH 3T12 fibroblasts, as well as the promoter that
directs transcription of this message. In addition, we have
presented data that demonstrate that the v-cyclin lytic cycle-
associated promoter is Rta responsive. We have yet to determine
experimentally whether Rta induction of the v-cyclin lytic
cycle-associated promoter is mediated by a direct or indirect
mechanism.
Both Rta and v-cyclin fall into the immediate-early class of
γHV68 transcripts in lytically infected cells (Martinez-Guzman et
al., 2003). As well, lytic infection of BHK cells with a virus that
overexpresses Rta leads to a 4-fold increase in v-cyclin
transcription by 4 h post-infection as compared to cells infected
with WT virus (Martinez-Guzmann et al., 2003). It is important
to note that Rta expression is necessary for lytic infection and
also sufficient to trigger virus reactivation in latently infected cells
(Pavlova et al., 2003; Wu et al., 2000, 2001). Thus, among the
genes required for γHV68 reactivation are those genes expressed
at immediate-early times in lytic infection. It follows that the
regulation of genes by Rta during lytic infection indicates a
regulatory role of Rta in virus reactivation. Taken together, these
results suggest v-cyclin is positioned downstream of Rta in the
regulatory cascade that results in γHV68 reactivation. Using a
γHV68 Rta-deficient virus, we are currently characterizing the
changes in transcription of specific immediate-early gene
transcripts in the absence of Rta. By this method we hope to
identify additional genes, like v-cyclin, that are dispensable for
lytic replication, but required for γHV68 reactivation.
Through systematic mutagenesis of the v-cyclin lytic
promoter, we have identified promoter regions that are critical
for transactivation by Rta, as well as basal expression of v-
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scanning mutations define regulatory regions that are required
for both transactivation by Rta and v-cyclin expression during
lytic infection. Conversely, the LS5 and LS6 mutations defined
promoter regions that are required for transactivation by Rta in
transient transfection reporter assays, but have no detectable
role in directing v-cyclin expression during lytic infection.
Thus, by placing the linker scanning mutations in the context of
the viral genome, we were able to identify those mutations
which, by virtue of their effects on lytic cycle-associated v-
cyclin expression, had the greatest chance of affecting v-cyclin
expression during γHV68 reactivation. Because v-cyclin
protein function is dispensable for the establishment of latent
infection in vivo, but plays an important role for efficient virus
reactivation, both in reactivation from latently infected PECs
(van Dyk et al., 2000) and splenocytes (Upton and Speck,
2006), we examined the in vivo role of the lytic cycle-associated
v-cyclin promoter in regulating v-cyclin expression during
reactivation. Results from these experiments suggest that the v-
cyclin lytic cycle-associated promoter is dispensable for
regulation of v-cyclin during virus reactivation. However,
because the mutations introduced did not completely abrogate
lytic cycle-associated v-cyclin expression, we cannot rule out a
role for the v-cyclin lytic promoter during virus reactivation.
Nevertheless, we hypothesize that v-cyclin expression during
γHV68 reactivation is regulated in a manner independent of v-
cyclin lytic cycle-associated expression. Indeed, there is
evidence that there are alternative mechanisms for regulating
v-cyclin expression. We have recently identified an alternatively
spliced v-cyclin transcripts present in a γHV68 latently infected
cell line (Allen et al., 2006). These transcripts share 5′ exons
with a transcript encoding the γHV68 LANA protein (orf 73).
We are currently pursuing experiments to determine the role of
this latency-associated v-cyclin transcript in virus reactivation.
It will also be important to establish the relative contribution of
the different v-cyclin gene promoters in the early and late stages
of virus reactivation in various infected cell types in vivo.
Materials and methods
Viruses and tissue culture
NIH 3T12 fibroblasts and murine embryonic fibroblasts were
maintained as previously described (Virgin et al., 1997). Vero Cre
cells were maintained in Dulbecco's modified Eagles media
(DMEM) supplemented with 10% fetal bovine serum, 100 U/ml
concentration of antibiotics, 2 mM L-glutamine, and 300 μg of
hygromycin B (Calbiochem) per ml. BAC-derived wild-type and
mutant virus stocks were grown and titered on Vero-Cre cells as
previously described (Moorman et al., 2004). The generation of the
72Stop virus has been described previously (van Dyk et al., 2000).
For analysis of v-cyclin expression during lytic infection, 2×105
NIH 3T12 fibroblasts were plated in 6 well plates and the
following day were infected at an moi of 5 with wild-type or
mutant virus stock in 200 μl of DMEM supplemented with 10%
fetal bovine serum, 100 U/ml concentration of antibiotics, and
2 mM L-glutamine (CMEM). Plates were incubated at 37 °C for1 h and rocked every 15 min. Following incubation, 2 ml of
prewarmed CMEM was added and plates were incubated for at
37 °C for 18 h prior to harvesting of infected cells for Western Blot
analysis (see below).
RACE
RNAwas harvested from infectedNIH 3T12 fibroblasts by lysis
of infected cells with guanidine isothiocyanate/phenol solution
(GITC-Phenol, 2 M Guanidine Isothiocyanate, 0.05 M β-
mercaptoethanol, 0.25% Sarcosyl 0.1M NaOAc) followed by
extraction with chloroform. RNA was then precipitated with
isopropanol and resuspended in RNase-free water. RACE was
carried out using theGeneRacer system (Invitrogen). The sequence
of the gene specific oligonucleotide primer used for 5′RACE,
72RACE5′, was 5′AGGTCTTTGCACACACAAAACATC-
CACGTG3′. The sequence of the gene specific oligonucleotide
primer used for 3′RACE, 72RACE3′, was 5′ACCCAGTTGG-
CATACCTTTG3′. PCR products were electrophoresed on 1%
agarose gels, and specific bands were excised and prepared for
ligation using GeneClean (Q-Biogene). Products were then T–A
subcloned into either pGEM-T (Promega) or pCR4-TOPO vector
(Invitrogen) and multiple subclones were analyzed by DNA
sequencing.
Primer extension
Primer extension reactions were carried out essentially as
described in Current Protocols in Molecular Biology (Ausubel et
al., 1992). Briefly, total cellular RNAwas harvested from infected
or uninfected cells using the GITC-Phenol extraction described
above. Polyadenylated RNA was then prepared from total RNA
using GenElute mRNA oligodT columns (Sigma). PolyA RNA
was hybridized with radiolabeled oligonucleotide probe
72RACE5′ by incubating the mixture at 65 °C for 90 min.
Following incubation, 30 μl of the following reaction mixture was
added to the hybridization reaction (0.9 μl 1 M Tris–Cl, pH 8.3,
0.9 μl 0.5M MgCl2, 0.25 μl 1 M dithiothreitol, 6.75 μl 1 mg/ml
antinomycin D, 1.33 μl 5 mM mixture of dATP, dTTP, dGTP, and
dCTP, 20 μl RNase free dH2O, and 0.2 μl 25 U/ μl AMV reverse
transcriptase). Samples were incubated at 42 °C for 1 h, and
reactions were stopped by adding 105 μl of RNase reaction mix
(100 μg/ml salmon sperm DNA, 20 μg/ml RnaseA in TEN 100
buffer). Samples were loaded onto 9% acrylamide/7M urea gel
along with a lambda gt11 sequencing reaction that served as a size
marker. Following electrophoresis, the gel was dried, exposed on a
phosphoimager screen, and screens were read on a Typhoon 9410
variable mode imager (GE Amersham).
Plasmids and constructs
Luciferase reporter constructs
For wild-type v-cyclin promoter constructs, PCR using WT
γHV68 BAC DNA template (Adler et al., 2001, 2003) was
performed with an oligonucleotide primer containing nucleotides
103,182 to 103,201 and one of the following oligonucleotide
primers: 72/100, nucleotide 103,282–103,262; 72/200, nucleotide
257R.D. Allen III et al. / Virology 365 (2007) 250–259103,382–103,362; 72/300, 103,482–103,462; 72/800, 103,982–
103,962. Products were digested with NheI and XhoI (restriction
sites were incorporated into the oligonucleotide primer sequences),
ligated into pGL3, and the resultant subclones were confirmed by
restriction enzyme digestion. For reporter constructs containing
putative Rta responsive elements, sense and antisense oligonucleo-
tide pairs comprising LS4–6 (103,287–103,316) or LS6–9
(103,307–103,346) were annealed and cloned into the NheI and
BglII site of the heterologous TATA luciferase reporter vector,
hsp-tata pGL3 as previously described (Lukac et al., 2001). The
sequences of the oligonucleotide primer pairs are as follows
with the BglII or NheI overhangs underlined: LS4–LS6_R_GL3,
5′-CTAGCTTTAGTACCTGAAACTAATTACATCATCTG-3′;
LS4-LS6_D_GL3, 5′-GATCTCAGATGATGTAATTAGTTT-
CAGGTACTAAA-3′; LS6-LS9_R_GL3, 5′-CTAGCAAA-
TAGCTGCGCACGCACAACACACCACTTT TTAGTACCT-3′;
LS6-LS9_D_GL3, 5′-GATCTAGGTACTAAAAAGT-
GGTGTG TTGTGCGTGCGCAGCTATTT-3′. Subclones
were screened by PCR with the vector oligonucleotide primers
pGL3_C (5′-GTGATGTCCACCTCGATATGTGCATC-3′) and
pGL3_D (5′-CTAGCAAAATAGGCTGTCCCCAGTG-3′),
which generate a 301 bp product without an insert and
increase in size concomitant with the insert size. Clones with
inserts were sequenced with the oligonucleotide primer
pGL3_C for verification. Linker scanning mutations were
generated by Quick Change mutagenesis (Stratagene) using
72/800 as a template. In each case, the 10 bp mutated region
was replaced by the 10 bp linker sequence, 5′-AGGCGCCCA-
3′, which contains an AscI restriction site. Candidate mutants
were screened by restriction enzyme digestion and confirmed
by DNA sequencing. The promoter sequences and coordinates
replaced in each linker scanning mutant are as follows: LS1, 5′-
GGTTCGGGTG-3′ (103,257–103,266); LS2, 5′-GAATACAAAA-
3′ (103,267–103,276); LS3, 5′-GACTTTATTC-3′ (103,277–
103,286); LS4, 5′-CAGATGATGT-3′ (103,287–103,296); LS5, 5′-
AATTAGTTTC-3′ (103,297–103,306); LS6, 5′-AGGTACTAAA-3′
(103,307–103,316); LS7, 5′-AAGTGGTGTG (103,317–103,326);
LS8, 5′-TTGTGCGTGC-3′ (103,327–103,336); LS9, 5′-GCAGC
TATTT-3′ (103,337–103,346).
Allelic exchange targeting vectors
AllBAC targeting constructswere generated on the backbone of
the suicide vector pGS284 (Smith and Enquist, 1999) and inserts
were subcloned into the SphI restriction site of the pGS284
polylinker. The linker scanning mutations were as described above
in the context of wild-type sequences extending from nucleotide
102,702 to 103,881. Allelic exchange mutagenesis was carried out
as previously described (Moorman et al., 2003) and the resultant
gHV68 72 LS BAC mutants were screened by AscI digestion
of PCR products amplified with primers 72CPR1 (5′-
GCGGCCGCTAGCGAAACAGTCTTC AAGAAGGCT-3′) and
72CPR2 (5′-GCGGCCGCTAGCTCTGCAGTCTTCTTCATT
TAA-3′). The presence of the intended mutation was confirmed
by DNA sequencing of the targeted region using viral DNA as
template. Briefly, primers 102,750–102,773_D (5′-AGCTACC-
CACGAGAGGGTATCCAG-3′) and 103,750–103,728_C (5′-
ATCCTCCGT CCAACTGCCGGGAC-3′) were used to PCRamplify a 1000 bp fragment from each mutant that was
subsequently cloned into pCR Blunt (Invitrogen Corporation) and
submitted for sequencing. TheRta expression plasmid pBKRtawas
constructed using the eukaryotic expression vector pBK-CMV
(Stratagene) as previously described (Liu et al., 2000).
Transient transfections
NIH 3T12 fibroblasts or 293T cells were plated at 3×105 or
2×105 cells per well, respectively in 6 well plates and were
transfected using Superfect reagent (Qiagen) the following day.
Transfected cells were harvested after incubation at 37 °C for
48 h. For luciferase assays, transfected cells were resuspended
in 200 μl 1× Passive Lysis Buffer (Promega) and incubated
15 min at room temperature. Lysates were added to 100 μl
luciferase substrate (Promega) and analyzed for luciferase
activity with a Turner 20/20 Luminometer (Turner Systems).
Immunoblotting and antibodies
NIH 3T12 cells were infected at an MOI of 5 for 1 h,
washed once with phosphate-buffered saline (PBS), and
replaced with complete medium for 18 h. Cells were harvested
by scraping and centrifugation; cell pellets were frozen at
−80 °C. Whole-cell lysates were prepared from cell pellets
resuspended in ELB with protease inhibitors (Upton and
Speck, 2006). Protein concentration was determined by A280
measurement on a NanoDrop spectrophotometer (NanoDrop
Technologies) and a total of 30 μg of total protein was loaded
per lane on a 15% sodium dodecyl sulfate (SDS)-polyacryla-
mide gel and semi-dry transferred to nitrocellulose membrane
for immunoblotting. Membranes were blocked at room
temperature in blocking buffer (PBS with 0.05% Tween-20
[PBS-T] and 5% nonfat milk) for 1 h before incubation with the
indicated primary antibody for 1 h. Blots were washed with
three changes of PBS-T before incubation with horseradish
peroxidase (HRP)-conjugated donkey anti-rabbit, anti-mouse
(Jackson Immunochemicals), or anti-chicken (Gallus Immuno-
tech) secondary antibodies at 1:2000, 1:2000, and 1:10,000
dilution, respectively, in blocking buffer for 1 h at room
temperature. Bound antibody complexes were detected by
enhanced chemiluminescence reagent (Amersham Biosciences)
and exposed to film. Primary antibodies used were rabbit
polyclonal anti-v-cyclin antiserum (van Dyk et al., 1999),
chicken poly-clonal anti-ORF59 (Upton et al., 2005), and
mouse anti-β-actin (Sigma).
Mice, infections, and organ harvests
Mice maintained at Yerkes National Primate Research
Center in accordance with all federal and university policies.
C57BL/6 mice were purchased from Jackson Laboratories.
Mice were age and sex matched and were infected at between 8
and 12 weeks of age. Mice were infected by intranasal injection
with 1×103 PFU of virus in 20 μl of complete DMEM. Upon
sacrifice, spleens were harvested and prepared for plating on
MEF monolayers as previously described (29).
258 R.D. Allen III et al. / Virology 365 (2007) 250–259Limiting dilution ex vivo reactivation assay
Detection of γHV68 reactivation was performed as previously
described (Weck et al., 1996, 1999). Briefly, splenocytes were
plated in two-fold serial dilutions, starting at 105 cells per well,
onto MEF monolayers in 96-well tissue culture plates. Twenty-
four wells were plated per dilution. Twenty-one days post plating,
wells were scored for the presence of cytopathic effect (CPE). To
detect preformed infectious virus, parallel samples were resus-
pended in 1/3×DMEM in the presence of 0.5-mm silica beads and
treated as previously described (Weck et al., 1996).Disrupted cells
were plated in a similar series of twofold dilutions and scored for
CPE as described above.
Statistical analyses
All data were analyzed using GraphPad Prism (GraphPad
Software, San Diego, Calif.). Titer data were statistically
analyzed using the nonparametric Mann–Whitney test. The
frequencies of reactivation were statistically analyzed using the
paired t test. To accurately obtain the frequency for each
limiting dilution, data were subjected to nonlinear regression
(using a sigmoidal dose curve with nonvariable slope to fit the
data). Frequencies of reactivation were obtained by calculating
the cell density at which 63% of the wells scored positive for
reactivating virus based on a Poisson distribution.
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